It is very uncertain whether summary of findings: repaglinide changes hypoglycemia: number of episodes compared with placebo (very low certainty).
Summary of findings: repaglinide showed no clear difference in hbA1c (%) change from baseline compared with insulin (high certainty).
Summary of findings: repaglinide showed no clear difference in FEV1 % predicted change from baseline compared with insulin (moderate certainty).
Summary of findings: repaglinide showed no clear difference in FVC % predicted change from baseline compared with insulin (moderate certainty).
Summary of findings: repaglinide showed no clear difference in BMI (kg/m²) change from baseline compared with insulin (low certainty).
Summary of findings: repaglinide showed no clear difference in hypoglycemia number of episodes compared with insulin (low certainty).
Summary of findings: repaglinide showed no clear difference in FEV1 % predicted; change from baseline compared with placebo (low certainty).
Summary of findings: repaglinide showed no clear difference in FVC % predicted: change from baseline compared with placebo (low certainty).
Summary of findings: repaglinide showed no clear difference in BMI (kg/m²): change from baseline compared with placebo (low certainty).